Dietary fortificant iron intake is negatively associated with quality of life in patients with mildly active inflammatory bowel disease

Nutrition and Metabolism

Volumn 10, Issue 1, 2013, Pages

  Powell, Jonathan J ^a   Cook, William B ^a   Hutchinson, Carol ^a   Tolkien, Zoe ^a   Chatfield, Mark ^a   Pereira, Dora I A ^a   Lomer, Miranda C E ^b,c  

^a MRC HUMAN NUTRITION RESEARCH   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Fortificant iron; IBD; Iron deficiency; Iron intake; Quality of life

Indexed keywords

HEMOGLOBIN; IRON;

ADULT; AGED; ANEMIA; ANXIETY; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DEPRESSION; DIGESTIVE SYSTEM EXAMINATION; DISEASE ASSOCIATION; DISEASE SEVERITY; EUROQOL 5D; FEMALE; FORTIFIED FOOD; HUMAN; INFLAMMATORY BOWEL DISEASE; IRON ABSORPTION; IRON BLOOD LEVEL; IRON INTAKE; MALE; MCMASTER INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE; NUTRITIONAL REQUIREMENT; PATIENT MOBILITY; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; SELF CARE; ULCERATIVE COLITIS; VISUAL ANALOG SCALE;

EID: 84872148380     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-10-9     Document Type: Article

References (32)

1. Gasche C, Reinisch W, Lochs H, Parsaei B, Bakos S, Wyatt J, Fueger GF, Gangl A: Anemia in Crohn's disease. Importance of inadequate erythropoietin production and iron deficiency. Dig Dis Sci 1994, 39:1930-1934.
2. Kulnigg S, Gasche C: Systematic review: managing anaemia in Crohn's disease. Aliment Pharmacol Ther 2006, 24:1507-1523.
3. Lakatos L, Pandur T, David G, Balogh Z, Kuronya P, Tollas A, Lakatos PL: Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study. World J Gastroenterol 2003, 9:2300-2307.
4. Gasche C, Dejaco C, Waldhoer T, Tillinger W, Reinisch W, Fueger GF, Gangl A, Lochs H: Intravenous iron and erythropoietin for anemia associated with Crohn disease. A randomized, controlled trial. Ann Intern Med 1997, 126:782-787.
5. Gasche C, Lomer MC, Cavill I, Weiss G: Iron, anaemia, and inflammatory bowel diseases. Gut 2004, 53:1190-1197.
6. de Silva AD, Tsironi E, Feakins RM, Rampton DS: Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective, comparative trial. Aliment Pharmacol Ther 2005, 22:1097-1105.
7. Harvey RS, Reffitt DM, Doig LA, Meenan J, Ellis RD, Thompson RP, Powell JJ: Ferric trimaltol corrects iron deficiency anaemia in patients intolerant of iron. Aliment Pharmacol Ther 1998, 12:845-848.
8. Lindgren S, Wikman O, Befrits R, Blom H, Eriksson A, Granno C, Ung KA, Hjortswang H, Lindgren A, Unge P: Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study. Scand J Gastroenterol 2009, 44:838-845.
9. de Silva AD, Mylonaki M, Rampton DS: Oral iron therapy in inflammatory bowel disease: usage, tolerance, and efficacy. Inflamm Bowel Dis 2003, 9:316-320.
10. Oldenburg B, Koningsberger JC, Van Berge Henegouwen GP, Van Asbeck BS, Marx JJ: Iron and inflammatory bowel disease. Aliment Pharmacol Ther 2001, 15:429-438.
11. Erichsen K, Ulvik RJ, Grimstad T, Berstad A, Berge RK, Hausken T: Effects of ferrous sulphate and non-ionic iron-polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2005, 22:831-838.
12. Carrier J, Aghdassi E, Cullen J, Allard JP: Iron supplementation increases disease activity and vitamin E ameliorates the effect in rats with dextran sulfate sodium-induced colitis. J Nutr 2002, 132:3146-3150.
13. Seril D, Liao NJ, et al: Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis 2003, 24(3):353-362.
14. Seril DN, Liao J, West AB, Yang GY: High-iron diet: foe or feat in ulcerative colitis and ulcerative colitis-associated carcinogenesis. J Clin Gastroenterol 2006, 40:391-397.
15. Seril DN, Liao J, Yang CS, Yang GY: Systemic iron supplementation replenishes iron stores without enhancing colon carcinogenesis in murine models of ulcerative colitis: comparison with iron-enriched diet. Dig Dis Sci 2005, 50:696-707.
16. Werner T, Wagner SJ, Martinez I, Walter J, Chang JS, Clavel T, Kisling S, Schuemann K, Haller D: Depletion of luminal iron alters the gut microbiota and prevents Crohn's disease-like ileitis. Gut 2011, 60:325-333.
17. Lomer MC, Cook WB, Jan-Mohamed HJ, Hutchinson C, Liu DY, Hider RC, Powell JJ: Iron requirements based upon iron absorption tests are poorly predicted by haematological indices in patients with inactive inflammatory bowel disease. Br J Nutr 2012, 107:1806-1811.
18. Stein J, Hartmann F, Dignass AU: Diagnosis and management of iron deficiency anemia in patients with IBD. Nat Rev Gastroenterol Hepatol 2010, 7:599-610.
19. Heath AL, Skeaff CM, Gibson RS: The relative validity of a computerized food frequency questionnaire for estimating intake of dietary iron and its absorption modifiers. Eur J Clin Nutr 2000, 54:592-599.
20. Harvey RF, Bradshaw JM: A simple index of Crohn's-disease activity. Lancet 1980, 1:514.
21. Guyatt G, Mitchell A, Irvine EJ, Singer J, Williams N, Goodacre R, Tompkins C: A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989, 96:804-810.
22. Irvine EJ, Zhou Q, Thompson AK: The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial. Am J Gastroenterol 1996, 91:1571-1578.
23. McCance, Widdowson: The Composition of Foods. In Food Standards Agency. 6th edition. Cambridge: Royal Society of Chemistry; 2002.
24. Conway RE, Geissler CA, Hider RC, Thompson RP, Powell JJ: Serum iron curves can be used to estimate dietary iron bioavailability in humans. J Nutr 2006, 136:1910-1914.
25. Wells CW, Lewis S, Barton JR, Corbett S: Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflammatory Bowel Diseases 2006, 12:123-130.
26. Gisbert JP, Bermejo F, Pajares R, Perez-Calle JL, Rodriguez M, Algaba A, Mancenido N, de la Morena F, Carneros JA, McNicholl AG, et al: Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvement. Inflamm Bowel Dis 2009, 15:1485-1491.
27. Thomson AB, Brust R, Ali MA, Mant MJ, Valberg LS: Iron deficiency in inflammatory bowel disease. Diagnostic efficacy of serum ferritin. Am J Dig Dis 1978, 23:705-709.
28. Crawford J, Cella D, Cleeland CS, Cremieux PY, Demetri GD, Sarokhan BJ, Slavin MB, Glaspy JA: Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy. Cancer 2002, 95:888-895
29. Erichsen K, Ulvik RJ, Nysaeter G, Johansen J, Ostborg J, Berstad A, Berge RK Hausken T: Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease. Scand J Gastroenterol 2005, 40:1058-1065
30. Zhu A, Kaneshiro M, Kaunitz JD: Evaluation and treatment of iron deficiency anemia: a gastroenterological perspective. Dig Dis Sci 2010, 55:548-559.
31. Gasche C, Berstad A, Befrits R, Beglinger C, Dignass A, Erichsen K, Gomollon F, Hjortswang H, Koutroubakis I, Kulnigg S, et al: Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis 2007, 13:1545-1553
32. Seril DN, Liao J, Ho KL, Warsi A, Yang CS, Yang GY: Dietary iron supplementation enhances DSS-induced colitis and associated colorectal carcinoma development in mice. Dig Dis Sci 2002, 47:1266-1278